News
Preventing cancer-related infection
- Author:
- Erilyn Riley
Publish date: September 27, 2014
Credit: CDC/Kimberly Smith and Christine Ford NEW YORK—Hand washing is still the single most effective method to prevent the transmission of...
News
Speaker offers alternatives for sustainable TKI use in CML
- Author:
- Erilyn Riley
Publish date: September 26, 2014
NEW YORK—If any oncology drugs warrant a high price, BCR-ABL tyrosine kinase inhibitors (TKIs) could make a strong case, according to a speaker at...
News
Split decision on role of upfront transplant in MM
- Author:
- Erilyn Riley
Publish date: September 26, 2014
Credit: Chad McNeeley NEW YORK—A debate on the pros and cons of upfront transplant in symptomatic multiple myeloma (MM) yielded a split decision...
News
New antibody achieves high CR rate in relapsed/refractory adult ALL
- Author:
- Erilyn Riley
Publish date: June 14, 2012
CHICAGO—A new monoclonal antibody, blinatumomab, achieves an “exceptionally high complete remission rate” as a single agent in acute lymphoblastic...
News
Pomalidomide and loDex achieve impressive results in MM
- Author:
- Erilyn Riley
Publish date: December 22, 2011
SAN DIEGO—Impressive results have been achieved with pomalidomide and low-dose dexamethasone (loDex) in relapsed and refractory patients with...
News
CD19-redirected T cells induce remission in CLL patients
- Author:
- Erilyn Riley
Publish date: August 10, 2011